$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Therapie des Pankreasadenokarzinoms
Therapy of pancreatic adenocarcinoma

Medizinische Klinik, v.94 no.11, 1999년, pp.614 - 625  

Böhmig, Michael ,  Wiedenmann, Bertram ,  Rosewicz, Stefan

Abstract ▼ AI-Helper 아이콘AI-Helper

Despite significant advances in the areas of epidemiology, risk factors, molecular genetics and diagnosis pancreatic carcinoma is characterized by a dismal prognosis and ranks 5th among malignancy-associated deaths. This article attempts to critically review the current literature and analyze therap...

참고문헌 (184)

  1. Cancer JD Ahlgren 8 654 1996 10.1002/(SICI)1097-0142(19960801)78:3<654::AID-CNCR46>3.0.CO;2-V Ahlgren JD. Chemotherapy for pancreatic carcinoma. Cancer 1996; 8: 654-63. 

    상세보기 crossref

  2. Semin Oncol JD Ahlgren 23 241 1996 Ahlgren JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996; 23: 241-50. 

    상세보기

  3. Cell C Almoguera 53 549 1988 10.1016/0092-8674(88)90571-5 Almoguera C, Shihabata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-54. 

    상세보기 crossref

  4. Semin Oncol CL Alter 23 229 1996 Alter CL. Palliative and supportive care of patients with pancreatic cancer. Semin Oncol 1996; 23: 229-40. 

    상세보기

  5. Scand J Gastroenterol JR Andersen 16 973 1981 10.3109/00365528109181013 Andersen JR, Friis-Moller A, Hancke S, et al. A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer. Scand J Gastroenterol 1981; 16: 973-5. 

    상세보기 crossref

  6. Gut JR Andersen 30 1132 1989 10.1136/gut.30.8.1132 Andersen JR, Sorenson SM, Kruse A, et al. Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30: 1132-5. 

    상세보기 crossref

  7. Scand J Gastroenterol A Andrén-Sandberg 32 97 1997 10.3109/00365529709000177 Andrén-Sandberg A. Etrologic links between chronic pancreatitis and pancreatic cancer. Scand J Gastroenterol 1997; 32: 97-103. 

    상세보기 crossref

  8. Int J Pancreat A Andrén-Sandberg 21 31 1997 10.1007/BF02785917 Andrén-Sandberg A, Bäckmann PL, Andersson R. Results of adjuvant therapy in resected pancreatic cancer. Int J Pancreat 1997; 21: 31-8. 

    상세보기 crossref

  9. Scand J Gastroenterol H Andrén-Sandberg 18 609 1983 10.3109/00365528309181646 Andrén-Sandberg H, Homberg JT, Ihse I. Treatment of unresectable pancreatic carcinoma with 5-fluoruracil, vincristine and CCNU. Scand J Gastroenterol 1983; 18: 609-12. 

    상세보기 crossref

  10. J Clin Oncol B Ardalan 6 1053 1988 10.1200/JCO.1988.6.6.1053 Ardalan B, Singh G, Silberman H. A randomized phase I and II study of short-term infusion of high dose fluoruracil with or without N-(phosphonoacetyl)-L-aspartic-acid in patients with advanced pancreatic and colorectal cancers. J Clin Oncol 1988; 6: 1053-8. 

    상세보기 crossref

  11. Cancer B Ardalan 74 1869 1994 10.1002/1097-0142(19941001)74:7<1869::AID-CNCR2820740707>3.0.CO;2-J Ardalan B, Ucar A, Reddy R, et al. Phase I trial of lowdose N-phosphonacetyl-l-aspartic acid and high dose 5-fluoruracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas. Cancer 1994; 74: 1869-73. 

    상세보기 crossref

  12. Ann Oncol M Auerbach 8 439 1997 10.1023/A:1008299429294 Auerbach M, Wampler GL, Lokich JJ, et al. Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluoruracil and weekly carboplatin: A Mid-Atlantic Oncology Program study. Ann Oncol 1997; 8: 439-44. 

    상세보기 crossref

  13. Eur J Cancer KE Bakkevold 29 698 1993 10.1016/S0959-8049(05)80349-1 Bakkevold KE, Arensjo B, Dahl O, et al. Adjuvant therapy (AMF) following radical resection of carcioma of the pancreas and papilla of Vater. Results of a controlled, prospective randomized multicentre study. Eur J Cancer 1993; 29: 698-703. 

    상세보기 crossref

  14. Br J Surg KE Bakkevold 77 725 1990 10.1002/bjs.1800770704 Bakkevold KE, Pettersen A, Arnesjo B, et al. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater. Br J Surg 1990; 77: 725-30. 

    상세보기 crossref

  15. Gastroenterology P Bansal 109 247 1995 10.1016/0016-5085(95)90291-0 Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 1995; 109: 247-51. 

    상세보기 crossref

  16. Br J Surg H Baumel 81 102 1994 10.1002/bjs.1800810138 Baumel H, Huguier M, Manderscheid JC, et al. Results of resection for cancer of the exocrine pancreas-a study from the French Association of Surgery. Br J Surg 1994; 81: 102-7. 

    상세보기 crossref

  17. HPB Surg L Belli 1 195 1989 10.1155/1989/94691 Belli L, Riolo F, Romani F, et al. Pylorus preserving pancreatoduodenectomy versus Whipple procedure for adenocarcinoma of the head of the pancreas. HPB Surg 1989; 1: 195-200. 

    상세보기 crossref

  18. Br J Cancer W Bergman 61 932 1990 10.1038/bjc.1990.209 Bergman W, Watson P, DeJong J, et al. Systemic cancer and the FAMMM syndrome. Br J Cancer 1990; 61: 932-6. 

    상세보기 crossref

  19. Lancet PC Bornman 1 69 1986 10.1016/S0140-6736(86)90719-1 Bornman PC, Harries-Jones EP, Tobias R, et al. Prospective controlled trial of transhepatic biliary endoprosthesis versus biliary bypass surgery for incurable carcinoma of head of pancreas. Lancet 1986; 1: 69-71. 

    상세보기 crossref

  20. Radiother Oncol JF Bosset 24 191 1992 10.1016/0167-8140(92)90379-9 Bosset JF, Pavy JJ, Gillet M, et al. Conventional external irradiation alone as adjuvant treatment in resectable pacreatic cancer: results of a prospective study. Radiother Oncol 1992; 24: 191-4. 

    상세보기 crossref

  21. Tumori G Boz 77 61 1991 10.1177/030089169107700115 Boz G, DePaoli A, Roncadin M, et al. Radiation therapy combined with chemotherapy for inoperable pancreatic carcinoma. Tumori 1991; 77: 61-4. 

    상세보기 crossref

  22. Ann Surg JW Braasch 204 411 1986 10.1097/00000658-198610000-00009 Braasch JW, Deziel DJ, Rossi RL, et al. Pyloric and gastric preserving pancreatic resections: experience with 87 patients. Ann Surg 1986; 204: 411-8. 

    상세보기 crossref

  23. Int J Pancreat SR Bramhall 21 1 1997 10.1007/BF02785914 Bramhall SR. The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int J Pancreat 1997; 21: 1-12. 

    상세보기 crossref

  24. Br J Surg SR Bramhall 82 111 1995 10.1002/bjs.1800820137 Bramhall SR, Allum AG, Jones AG, et al. Treatment and survival of 12560 patients with pancreatic cancer, and incidence of the disease, in the West midlands: an epidemiological study. Br J Surg 1995; 82: 111-5. 

    상세보기 crossref

  25. Int J Pancreatol SR Bramhall 21 59 1997 10.1007/BF02785921 Bramhall SR, Neoptolemos JP. Adjuvant chemotherapy in pancreatic cancer. Int J Pancreatol 1997; 21: 59-63. 

    상세보기 crossref

  26. Cancer FH Brembeck 83 2317 1998 10.1002/(SICI)1097-0142(19981201)83:11<2317::AID-CNCR11>3.0.CO;2-P Brembeck FH, Schoppmeyer K, Leupold U, et al. A phase II pilot trial of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma. Cancer 1998; 83: 2317-23. 

    상세보기 crossref

  27. MF Brennan 849 1993 Cancer principles and practice of oncology Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. In: de Vita V, Hellmann S, Rosenberg SA. Cancer principles and practice of oncology. Philadelphia: Lippincott, 1993: 849-82. 

  28. MW Büchler 309 1996 Advances in pancreatic disease Büchler MW, Wagner M, Friess H. Surgery for pancreatic cancer. In: Dervenis CG. Advances in pancreatic disease. Stuttgart: Thieme, 1996: 309-23. 

  29. Cancer RM Bukowski 52 1577 1983 10.1002/1097-0142(19831101)52:9<1577::AID-CNCR2820520906>3.0.CO;2-8 Bukowski RM, Balcerak SP, O’Brian RM, et al. Randomized trial of 5-fluoruracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. Cancer 1983; 52: 1577-82. 

    상세보기 crossref

  30. Eur J Cancer H Burris 1 18 1997 10.1016/S0959-8049(96)00324-3 Burris H, Stornioli AM. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluoruracil. Eur J Cancer 1997; 1: 18-22. 

    상세보기 crossref

  31. J Clin Oncol HA Burris 6 2403 1997 10.1200/JCO.1997.15.6.2403 Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997; 6: 2403-13. 

    상세보기 crossref

  32. Nat Genet C Caldas 8 27 1994 10.1038/ng0994-27 Caldas C, Hahn SA, daCosta LT, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8: 27-32. 

    상세보기 crossref

  33. Cancer Res C Caldas 54 3568 1994 Caldas C, Hahn SA, Hruban RH, et al. Detection of Kras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-673. 

    상세보기

  34. Am J Surg JL Cameron 161 120 1991 10.1016/0002-9610(91)90371-J Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-5. 

    상세보기 crossref

  35. Cancer AG Caraceni 78 Suppl 639 1996 10.1002/(SICI)1097-0142(19960801)78:3<639::AID-CNCR45>3.0.CO;2-X Caraceni AG, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer 1996;Suppl:78: 639-53. 

    상세보기 crossref

  36. Br J Cancer J Carmichael 73 101 1996 10.1038/bjc.1996.18 Carmichael J, Fink U, Russell RCG, et al. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 1996;73:101-5. 

    상세보기 crossref

  37. Cancer Treat Rev SK Carter 2 193 1975 10.1016/S0305-7372(75)80003-X Carter SK, Comis L. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev 1975; 2:193-214. 

    상세보기 crossref

  38. Invest New Drugs ES Casper 12 29 1994 10.1007/BF00873232 Casper ES, Green MR, Kelsen DP, et al. Phase II trial of gemcitabine in patients with adenocarcinoma of the pancreas. Invest New Drugs 1994;12:29-34. 

    상세보기 crossref

  39. Cancer RT Chlebowski 59 406 1987 10.1002/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO;2-W Chlebowski RT, Bilcavage L, Grosvenor M, et al. Hydrazine sulfate in cancer patients with weight loss: a placebo-controlled clinical experience. Cancer 1987;59:406-10. 

    상세보기 crossref

  40. Cancer Invest ML Citron 10 335 1992 10.3109/07357909209024792 Citron ML, Kalra JM, Seltzer VL, et al. Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use. Cancer Invest 1992;10:335-41. 

    상세보기 crossref

  41. Cancer JW Clark 78 688 1996 10.1002/(SICI)1097-0142(19960801)78:3+<688::AID-CNCR14>3.0.CO;2-2 Clark JW, Glicksman AS, Wanebo HJ. Systemic and adjuvant therapy for patients with pancreatic carcinoma. Cancer 1996;Suppl 78:688-93. 

    상세보기 crossref

  42. Ann Surg KC Conlon 223 271 1996 Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Ann Surg 1996;223:271-9. 

  43. J Clin Oncol J Crown 9 1682 1991 10.1200/JCO.1991.9.9.1682 Crown J, Casper ES, Botet J, et al. Lack of efficacy of highdose leucovorin and fluoruracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol 1991;9:1682-6. 

    상세보기 crossref

  44. Eur J Cancer AM Cull 33 Suppl 6 3 1997 10.1016/S0959-8049(97)00194-9 Cull AM. Cancer-specific quality of life questionnaires: the state of the art in europe. Eur J Cancer 1997;33:Suppl 6:S3-7. 

    상세보기 crossref

  45. Cancer S Cullinan 65 2207 1990 10.1002/1097-0142(19900515)65:10<2207::AID-CNCR2820651007>3.0.CO;2-Y Cullinan S, Moertel CG, Wienand HS, et al. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluation of the Mallinson regimen and combined 5-fluoruracil, doxorubicin, and cisplatin. Cancer 1990;65: 2207-12. 

    상세보기 crossref

  46. JAMA SA Cullinan 253 2061 1985 10.1001/jama.1985.03350380077025 Cullinan SA, Moertel CG, Fleming TR, et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluoruracil vs fluoruracil and doxorubicin vs fluoruracil, doxorubicin and mitomycin. JAMA 1985;253:2061-7. 

    상세보기 crossref

  47. J Clin Oncol JA DeCaprio 9 2128 1991 10.1200/JCO.1991.9.12.2128 DeCaprio JA, Mayer RJ, Gonin R, et al. Fluoruracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial. J Clin Oncol 1991;9:2128-33. 

    상세보기 crossref

  48. Deutsches Krebsforschungszentrum (DKFZ). Krebskalender 1997. 

  49. Int J Radiat Biol Phys RR Dobelbower 39 31 1997 10.1016/S0360-3016(97)00125-9 Dobelbower RR, Merrick HW, Khuder S, et al. Adjuvant radiation therapy for pancreatic cancer: A 15-year-experience. Int J Radiat Biol Phys 1997;39:31-7. 

    상세보기 crossref

  50. J Natl Cancer Inst S Downer 82 1127 1990 10.1093/jnci/82.13.1127 Downer S, Joel S, Albright A, et al. A double blind placebo controlled trial of medroxyprogesterone acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990;82:1127-32. 

    상세보기 crossref

  51. Gastroenterology JF Dowsett 96 128A 1989 10.1016/0016-5085(89)91639-9 Dowsett JF, Russell RCG, Hatfield ARW, et al. Malignant obstructive jaundice: a prospective randomized trial of bypass-surgery versus endoscopic stenting. Gastroenterology 1989;96:128A. 

    상세보기 crossref

  52. Cancer SB Edge 71 3502 1993 10.1002/1097-0142(19930601)71:11<3502::AID-CNCR2820711107>3.0.CO;2-N Edge SB, Schmieg RE, Rosenhof LK, et al. Pancreas cancer resection outcome in American university centers in 1989-1990. Cancer 1993;71:3502-8. 

    상세보기 crossref

  53. JAMA J Everhart 273 1605 1995 10.1001/jama.1995.03520440059037 Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA 1995;273: 1605-9. 

    상세보기 crossref

  54. Ann Surg TJ Farrell 226 66 1997 10.1097/00000658-199707000-00009 Farrell TJ, Barbot DJ, Rosato FE. Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer. Ann Surg 1997;226:66-9. 

    상세보기 crossref

  55. Pancreas E Fernandez 11 185 1995 10.1097/00006676-199508000-00012 Fernandez E, LaVecchia CL, Porta M, et al. Pancreatitis and the risk of pancreatic cancer. Pancreas 1995;11:185-9. 

    상세보기 crossref

  56. Curr Opin Gastroenterol C Fernandez-del Castillo 10 507 1994 10.1097/00001574-199409000-00006 Fernandez-del Castillo C, Warshaw AL. Pancreatic carcinoma. Curr Opin Gastroenterol 1994;10:507-12. 

    상세보기 crossref

  57. J Med Genet TY Flanders 33 889 1996 10.1136/jmg.33.11.889 Flanders TY, Foulkes WD. Pancreatic adenocarcinoma: epidemiology and genetics. J Med Genet 1996; 33:889-98. 

    상세보기 crossref

  58. KM Foley 148 1993 Oxford textbook of palliative medicine Foley KM. Pain assessment of cancer pain syndromes. In: Doyle D, Hanks GW, MacDonald N. Oxford textbook of palliative medicine. Oxford: Oxford: University Press 1993:148-65. 

  59. J Natl Cancer Inst J Folkman 82 4 1990 10.1093/jnci/82.1.4 Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6. 

    상세보기 crossref

  60. Ann Surg JG Fortner 199 418 1984 10.1097/00000658-198404000-00008 Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Ann Surg 1984;199:418-25. 

    상세보기 crossref

  61. Am J Psychiatry I Fras 123 1553 1967 10.1176/ajp.123.12.1553 Fras I, Litin E, Pearson J. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasma. Am J Psychiatry 1967;123:1553-62. 

    상세보기 crossref

  62. Proc Am Assoc Cancer Res and Am Soc Clin Oncol MA Friedman 22 156 1981 Friedman MA, Cassidy MJ, Hannigan JF, et al. A phase III study of adriamycin+5FU vs BCNU+adriamycin+ftorafur for patients with advanced pancreatic cancer. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 1981; 22:156. 

  63. Digestion H Friess 58 557 1997 10.1159/000201501 Friess H, Kleeff J, Gumbs A, et al. Molecular versus conventional markers in pancreatic cancer. Digestion 1997; 58:557-63. 

    상세보기 crossref

  64. Cancer Res H Friess 53 2704 1993 Friess H, Yamanaka Y, Büchler MW, et al. Enhanced expression of the type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of the type III receptor. Cancer Res 1993;53:2704-7. 

    상세보기

  65. Arch Intern Med CS Fuchs 156 2250 1997 Fuchs CS, Colditz GA, Sampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1997;156:2250-60. 

  66. Cancer Gastrointestinal Tumor Study Group 59 2006 1987 10.1002/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of carcinoma of the pancreas. Cancer 1987;59:2006-10. 

    상세보기 crossref

  67. J Clin Oncol Gastrointestinal Tumor Study Group 4 1794 1986 10.1200/JCO.1986.4.12.1794 Gastrointestinal Tumor Study Group. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluoruracil plus doxorubicin plus mitomycin C and two regimens of streoptozotocin plus mitomycin plus fluoruracil. J Clin Oncol 1986;4:1794-8. 

    상세보기 crossref

  68. Cancer Gastrointestinal Tumor Study Group 56 2563 1985 10.1002/1097-0142(19851201)56:11<2563::AID-CNCR2820561104>3.0.CO;2-0 Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluoruracil for the treatment of locally unresectable cancer. Cancer 1985;56: 2563-8. 

    상세보기 crossref

  69. J Natl Cancer Inst Gastrointestinal Tumor Study Group 80 751 1988 10.1093/jnci/80.10.751 Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined modality treatment (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80:751-5. 

    상세보기 crossref

  70. Am J Surg RF Geer 165 68 1993 10.1016/S0002-9610(05)80406-4 Geer RF, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-73. 

    상세보기 crossref

  71. Int J Pancreatol P Ghadirian 16 204 1994 Ghadirian P, Howe GR. Nutrition, alcohol and coffee and cancer of the pancreas. Int J Pancreatol 1994;16:204-7. 

  72. Ann Oncol B Glimelius 7 593 1996 10.1093/oxfordjournals.annonc.a010676 Glimelius B, Hoffmann K, Sjödén PO, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600. 

    상세보기 crossref

  73. N Engl J Med AM Goldstein 333 970 1995 10.1056/NEJM199510123331504 Goldstein AM, Fraser MC, Streuwing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p161NK4 mutations. N Engl J Med 1995;333:970-4. 

    상세보기 crossref

  74. Cancer Lett L Gordis 52 1 1990 10.1016/0304-3835(90)90070-E Gordis L. Consumption of methylxanthine-containing beverages and risk of pancreatic cancer. Cancer Lett 1990; 52:1-12. 

    상세보기 crossref

  75. Am J Surg PA Grace 151 141 1986 10.1016/0002-9610(86)90024-3 Grace PA, Pitt HA, Tompkins PK, et al. Decreased morbidity and mortality after pancreatectomy. Am J Surg 1986;151:141-9. 

    상세보기 crossref

  76. Br J Surg PA Grace 73 647 1986 10.1002/bjs.1800730824 Grace PA, Pitt HA, Longmire WP. Pancreatoduodenectomy with pylorus preservation for adenocarcinoma of the head of the pancreas. Br J Surg 1986;73:647-50. 

    상세보기 crossref

  77. Digestion A Grahm 58 542 1997 10.1159/000201499 Grahm A, Andrén-Sandberg. A prospective evaluation of pain in exocrine pancreatic cancer. Digestion 1997; 58:542-9. 

    상세보기 crossref

  78. Psychosomatics A Green 34 202 1993 10.1016/S0033-3182(93)71882-4 Green A, Austin C. Psychopathology of pancreatic cancer: A psychobiologic probe. Psychosomatics 1993;34: 202-21. 

    상세보기 crossref

  79. Cancer JF Griffin 66 56 1990 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6 Griffin JF, Smalley R, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56-61. 

    상세보기 crossref

  80. Cancer B Gudjonsson 60 2284 1987 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-303. 

    상세보기 crossref

  81. J Am Coll Surg B Gudjonsson 181 483 1995 Gudjonsson B. Carcinoma of the pancreas: Critical analysis of costs, results of resections, and the need of standardized reporting. J Am Coll Surg 1995;181:483-503. 

    상세보기

  82. N Engl J Med L Gullo 331 81 1994 10.1056/NEJM199407143310203 Gullo L, Pezzilli R, Morselli-Labate AM and the Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994;331:81-4. 

    상세보기 crossref

  83. Dtsch Ärztebl SA Hahn 94 3342 1997 Hahn SA, Kern SE, Schmiegel WH. Neue molekularbiologische Erkenntnisse aus der Pankreaskarzinom-Forschung. Dtsch Ärztebl 1997;94:3342-50. 

  84. Science SA Hahn 217 350 1996 10.1126/science.271.5247.350 Hahn SA, Schutte M, Hoque ATM, et al. DPC4, A candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;217:350-3. 

    상세보기 crossref

  85. Hepatogastroenterology D Henne-Bruns 45 855 1998 Henne-Bruns D, Vogel I, Luttges J, et al. Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy. Hepatogastroenterology 1998;45:855-66. 

    상세보기

  86. Am J Psychiatry JC Holland 143 982 1986 10.1176/ajp.143.8.982 Holland JC, Korzun A, Tross S, et al. Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 1986;143:982-6. 

    상세보기 crossref

  87. Cancer Causes Control GR Howe 7 69 1996 10.1007/BF00115639 Howe GR, Burch JD. Nutrition and pancreatic cancer. Cancer Causes Control 1996;7:69-82. 

    상세보기 crossref

  88. Am J Pathol RH Hruban 143 545 1993 Hruban RH, van Mansfeld AD, Offerhaus GJA, et al. Kras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-54. 

    상세보기

  89. Am J Surg M Huguier 1264 348 1992 10.1016/S0002-9610(05)80903-1 Huguier M, Samama G, Testart J, et al. Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Assiocations for Surgical Research. Am J Surg 1992;1264:348-53. 

    상세보기 crossref

  90. Cancer J Inagaki 33 568 1974 10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2 Inagaki J, Rodriguez V, Bodey GP. Proceedings: Causes of death in cancer patients. Cancer 1974;33:568-73. 

    상세보기 crossref

  91. Br J Surg J Jeekel 78 1332 1991 10.1002/bjs.1800781121 Jeekel J, Treurniet-Donker AD. Treatment perspectives in locally advanced unresectable pancreatic cancer. Br J Surg 1991;78:1332-4. 

    상세보기 crossref

  92. Gen Hosp Psychiatry R Joffe 8 241 1986 10.1016/0163-8343(86)90004-6 Joffe R, Rubinow D, Demicoff K, et al. Depression and carcinoma of the panceas. Gen Hosp Psychiatry 1986; 8:241-5. 

    상세보기 crossref

  93. Arch Surg MH Kalser 120 899 1985 10.1001/archsurg.1985.01390320023003 Kalser MH, Ellengerg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903. 

    상세보기 crossref

  94. Gastroenterology BM Karlson 113 587 1996 10.1053/gast.1997.v113.pm9247480 Karlson BM, Ekbom A, Josefsson S, et al. The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology 1996;113:587-92. 

    상세보기 crossref

  95. Br J Cancer JJ Keating 69 789 1989 10.1038/bjc.1989.361 Keating JJ, Johnson PJ, Cochrane AM, et al. A prospective randomized controlled trial of tamoxifen and cyproteronacetate in pancreatic carcinoma. Br J Cancer 1989;69:789-92. 

    상세보기 crossref

  96. Cancer D Kelsen 68 965 1991 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2 Kelsen D, Hudis C, Niedzwiecki D, et al. A phase III comparison of streptozotocin, mitomycin, and 5-fluoruracil with cisplatin, cytosin arabinoside and caffein in patients with advanced pancreatic cancer. Cancer 1991: 68:965-9. 

    상세보기 crossref

  97. J Clin Oncol D Kelsen 13 748 1995 10.1200/JCO.1995.13.3.748 Kelsen D, Portenoy R, Thaler H, et al. Pain and depression in patients with newly diagnosed pancreatic cancer. J Clin Oncol 1995;13:748-55. 

    상세보기 crossref

  98. Cancer TJ Kinsella 78 Suppl 3 598 1996 10.1002/(SICI)1097-0142(19960801)78:3+<598::AID-CNCR4>3.0.CO;2-7 Kinsella TJ, Sindelar WF. Intraoperative radiotherapy for pancreatic carcinoma. Experimental and clinical studies. Cancer 1996;78:Suppl 3:598-604. 

    상세보기 crossref

  99. J Clin Oncol DJ Klaasen 3 373 1985 10.1200/JCO.1985.3.3.373 Klaasen DJ, MacIntyre JM, Catton GE, et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluoruracil alone with radiation plus concurrent and maintenance 5-fluoruracil. An Eastern Cooperative Oncology Group Study. J Clin Oncol 1985;3:373-8. 

    상세보기 crossref

  100. 1996 WHO: International histological classification of tumours: Histological typing of tumours of the exocrine pancreas Klöppel G, Solcia E, Longnecker DS, et al., eds. WHO: International histological classification of tumours: Histological typing of tumours of the exocrine pancreas. Berlin: Springer, 1996. 

  101. J Clin Invest M Kore 90 1352 1992 10.1172/JCI116001 Kore M, Chandrasekar B, Yamanaka Y, et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the level of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90: 1352-60. 

    상세보기 crossref

  102. Pain management of pancreatic carcinoma: a review. Pain AH Lebowits 36 1 1989 Lebowits AH, Lefkowitz M. Pain management of pancreatic carcinoma: a review. Pain 1989;36:1-11. 

  103. Digestion NR Lemoine 58 550 1997 10.1159/000201500 Lemoine NR. Molecular advances in pancreatic cancer. Digestion 1997;58:550-6. 

    상세보기 crossref

  104. Ann Surg KD Lillemoe 221 133 1995 10.1097/00000658-199502000-00003 Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg 1995;221:133-48. 

    상세보기 crossref

  105. Ann Surg DK Lillemoe 217 447 1993 10.1097/00000658-199305010-00004 Lillemoe DK, Cameron JL, Kaufmann HS, et al. Chemical splanchnectomy in patients with unresectable pancreatic cancer: a prospective randomized trial. Ann Surg 1993;217:447-57. 

    상세보기 crossref

  106. Cancer KD Lillemoe 78 Suppl 3 609 1996 Lillemoe KD, Pitt HA. Palliation - surgical and otherwise. Cancer 1996;78:Suppl 3:609-14. 

  107. Eur J Cancer R Lionetto 31 882 1995 10.1016/0959-8049(94)00445-5 Lionetto R, Pugliese V, Bruzzi P, et al. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 1995;31:882-7. 

    상세보기 crossref

  108. J Clin Oncol CL Loprinzi 11 152 1993 10.1200/JCO.1993.11.1.152 Loprinzi CL, Schaid DH, Dose AM, et al. Body-composition changes in patients who gain weight while receiving megestrol acetat. J Clin Oncol 1993;11:152-4. 

    상세보기 crossref

  109. N Engl J Med AB Lowenfels 328 1433 1993 10.1056/NEJM199305203282001 Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1433-7. 

    상세보기 crossref

  110. J Natl Cancer Inst AB Lowenfels 89 442 1997 10.1093/jnci/89.6.442 Lowenfels AB, Maissonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997;89:442-6. 

    상세보기 crossref

  111. Semin Oncol AT Lynch 23 251 1996 Lynch AT, Smyrk T, Kern SE, et al. Familial pancreatic cancer: A review. Semin Oncol 1996;23:251-75. 

    상세보기

  112. Am J Gastroenterol HT Lynch 85 54 1990 Lynch HT, Fiotzsimmons ML, Smyrk, TC, et al. Familial pancreatic carcinoma: clinicopathologic study of 128 nuclear families. Am J Gastroenterol 1990;85:54-60. 

    상세보기

  113. J Natl Cancer Inst TM Mack 76 49 1986 Mack TM, Yu MC, Hanisch R, et al. Pancreas cancer and smoking, beverage consumption and past medical history. J Natl Cancer Inst 1986;76:49-60. 

  114. Br Med J CN Mallinson 281 1589 1980 10.1136/bmj.281.6255.1589 Mallinson CN, Rake MO, Cocking JB. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomized multicentre trial. Br Med J 1980;281: 1589-91. 

    상세보기 crossref

  115. J Occup Med T Mancuso 9 277 1967 Mancuso T, El-Attar A. Cohort study of workers exposed to betanaphthylamine and benzidine. J Occup Med 1967;9:277-85. 

  116. Nutrition AJ McGeer 6 233 1996 McGeer AJ, Detsky AS, O’Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition 1996;6:233-40. 

  117. Semin Oncol PC McGrath 23 200 1996 McGrath PC, Sloan DA, Kenady DE. Surgical management of pancreatic carcinoma. Semin Oncol 1996;23: 200-12. 

    상세보기

  118. Pain S Mercadante 52 187 1993 10.1016/0304-3959(93)90130-H Mercadante S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 1993;52:187-92. 

    상세보기 crossref

  119. Cancer CG Moertel 48 1705 1981 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4 Moertel CG, Frytag S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluoruracil), and high dose radiation+5-fluoruracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-10. 

    상세보기 crossref

  120. J Clin Oncol M Mohiuddin 13 2764 1995 10.1200/JCO.1995.13.11.2764 Mohiuddin M, Regine WF, Stevens J, et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 1995;13:2764-8. 

    상세보기 crossref

  121. Cancer M Moore 78 Suppl 3 633 1996 10.1002/(SICI)1097-0142(19960801)78:3+<633::AID-CNCR8>3.0.CO;2-B Moore M. Activity of gemcitabine in patients with advanced pancreatic carcinoma. Cancer 1996;78:Suppl 3: 633-7. 

    상세보기 crossref

  122. Lancet DE Moulin 337 465 1991 10.1016/0140-6736(91)93401-T Moulin DE, Kreeft JH, Murray PN, et al. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 1991;337:465-8. 

    상세보기 crossref

  123. Cancer Epidemiol Biomarkers Prev JE Muscat 6 15 1997 Muscat JE, Stellmann SD, Hoffmann D, et al. Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev 1997;6:15-9. 

  124. Digestion JP Neoptolemos 58 570 1997 10.1159/000201503 Neoptolemos JP, Kerr DJ, Beger H, et al. ESPAC-1 Trial Progress Report: The European Randomized Adjuvant Study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion 1997;58:570-7. 

    상세보기 crossref

  125. Int J Radiation Biol Phys Y Nishimura 39 39 1997 10.1016/S0360-3016(97)00295-2 Nishimura Y, Hosotani R, Shibamoto Y, et al. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int J Radiation Biol Phys 1997;39:39-49. 

    상세보기 crossref

  126. Durgs S Noble 54 447 1997 Noble S, Goa KL. Gemcitabine: A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Durgs 1997:54:447-72. 

  127. Mod Pathol GJ Offerhaus 1 352 1988 Offerhaus GJ, Tersmette AC, Tersmette KW, et al. Gastric, pancreatic, and colorecal carcinogenesis following remote peptic ulcer surgery. Review of the literature with the emphasis on risk assessment and underlying mechanism. Mod Pathol 1988;1:352-6. 

    상세보기

  128. Am J Clin Oncol MM Oken 5 549 1982 Oken MM, Creech RH, Romey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:549-55. 

  129. Cancer MW Oster 57 29 1986 10.1002/1097-0142(19860101)57:1<29::AID-CNCR2820570108>3.0.CO;2-L Oster MW, Gray R, Panasci L, et al., for Cancer and Leukemia Group B. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluoruracil, adriamycin and mitomycin (FAM) with 5-fluoruracil, streptozotocin and mitomycin (FSM). Cancer 1986;57:29-33. 

    상세보기 crossref

  130. Br J Surg KR Palmer 81 882 1994 10.1002/bjs.1800810629 Palmer KR, Kerr M, Knowles G, et al. Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 1994;81:882-5. 

    상세보기 crossref

  131. Cancer SD Passik 78 Suppl 3 615 1996 10.1002/(SICI)1097-0142(19960801)78:3+<615::AID-CNCR6>3.3.CO;2-5 Passik SD, Breitbart WS. Depression in patients with pancreatic carcioma. Cancer 1996;78:Suppl 3:615-25. 

    crossref

  132. Arch Surg AG Patel 130 838 1995 10.1001/archsurg.1995.01430080040005 Patel AG, Toyama MT, Kusske AM, et al. Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better? Arch Surg 1995;130:838-42. 

    상세보기 crossref

  133. Cancer R Pazdur 70 2073 1992 10.1002/1097-0142(19921015)70:8<2073::AID-CNCR2820700810>3.0.CO;2-A Pazdur R, Ajani JJ, Abbruzzese JL, et al. Phase II evaluation of fluoruracil and recombinant alpha-2b-interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer 1992;70:2073-6. 

    상세보기 crossref

  134. Ann Surg S Pedrazzoli 228 508 1998 10.1097/00000658-199810000-00007 Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of pancreatic head cancer. A multicenter prospective randomized study. Lymphadenectomy study group. Ann Surg 1998;228:508-17. 

    상세보기 crossref

  135. Cancer Res NS Pellegata 54 1556 1994 Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and non-ductal tumours progress through different genetic lesions. Cancer Res 1994;54:1556-60. 

    상세보기

  136. N Engl J Med J Permert 330 313 1994 10.1056/NEJM199402033300503 Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994;330:313-8. 

    상세보기 crossref

  137. Cancer JM Pluda 78 680 1996 10.1002/(SICI)1097-0142(19960801)78:3+<680::AID-CNCR13>3.0.CO;2-2 Pluda JM, Parkinson DR. Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas. Cancer 1996;78:680-7. 

    상세보기 crossref

  138. Br J Cancer FJ Prott 75 597 1997 10.1038/bjc.1997.104 Prott FJ, Schönekaes K, Preusser P, et al. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study. Br J Cancer 1997;75:597-601. 

    상세보기 crossref

  139. Br J Surg JD Roder 79 152 1992 10.1002/bjs.1800790219 Roder JD, Stein HJ, Huttl W, et al. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 1992;79:152-5. 

    상세보기 crossref

  140. Lancet S Rosewicz 359 485 1997 10.1016/S0140-6736(96)05523-7 Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997;359:485-9. 

    상세보기 crossref

  141. Gastroenterology S Rosewicz 109 1646 1995 10.1016/0016-5085(95)90655-X Rosewicz S, Stier U, Brembeck F, et al. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 1995;109:1646-60. 

    상세보기 crossref

  142. N Engl J Med AH Ross 307 519 1982 10.1056/NEJM198208263070902 Ross AH, Smith MA, Anderson JR, et al. Late mortality after surgery for peptic ulcer. N Engl J Med 1982;307:519-22. 

    상세보기 crossref

  143. Cancer Chemother Pharmacol E Rosvold 29 305 1992 10.1007/BF00685949 Rosvold E, Schilder RJ, Walczak J. Phase II trial of PALA in combination with 5-fluoruracil in advanced pancreatic cancer. Cancer Chemother Pharmacol 1992;29: 305-8. 

    상세보기 crossref

  144. Cancer ML Rothenberg 67 627 1996 10.1002/(SICI)1097-0142(19960801)78:3<627::AID-CNCR43>3.3.CO;2-E Rothenberg ML, Abbruzzese JL, Moore M, et al. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer 1996;67: 627-32. 

    crossref

  145. Ann Oncol ML Rothenberg 7 347 1996 10.1093/oxfordjournals.annonc.a010600 Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996;7:347-53. 

    상세보기 crossref

  146. Cancer H Rothmann 68 264 1991 10.1002/1097-0142(19910715)68:2<264::AID-CNCR2820680208>3.0.CO;2-5 Rothmann H, Cantrell JE, Lokich J, et al. Continuous infusion of 5-fluouracil plus weekly cisplatin for pancreatic carcinoma: A Mid-Atlantic Oncology Program Study. Cancer 1991;68:264-8. 

    상세보기 crossref

  147. Surg Clin North Am D Saltzburg 69 629 1989 10.1016/S0039-6109(16)44839-5 Saltzburg D, Foley KM. Management of pain in pancreatic cancer. Surg Clin North Am 1989;69:629-49. 

    상세보기 crossref

  148. Am J Pathol A Scarpa 142 1534 1993 Scarpa A, Capelli P, Mukai K, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993;142:1534-43. 

    상세보기

  149. Cancer PS Schein 42 19 1978 10.1002/1097-0142(197807)42:1<19::AID-CNCR2820420103>3.0.CO;2-4 Schein PS, Lavin PT, Moertel CG, et al. Randomized phase II clinical trial of adriamycin, methotrexate and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group report. Cancer 1978;42:19-22. 

    상세보기 crossref

  150. Proc Natl Acad Sci USA W Schmiegel 94 12622 1997 10.1073/pnas.94.23.12622 Schmiegel W, Schmielau J, Henne-Bruns D, et al. Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to therapy of pancreatic cancer. Proc Natl Acad Sci USA 1997;94:12622-6. 

    상세보기 crossref

  151. Semin Oncol SF Schnall 23 220 1996 Schnall SF, Macdonald JS. Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol 1996;23:220-8. 

    상세보기

  152. Cancer G Seydel 65 1478 1990 10.1002/1097-0142(19900401)65:7<1478::AID-CNCR2820650705>3.0.CO;2-3 Seydel G, Stablein DM, Leichman LP, et al. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. Cancer 1990;65:1478-82. 

    상세보기 crossref

  153. Br Surg HA Shepherd 75 1166 1988 10.1002/bjs.1800751207 Shepherd HA, Royle G, Ross APR, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br Surg 1988;75:1166-8. 

    상세보기 crossref

  154. J Natl Cancer Inst DT Silverman 86 1510 1994 10.1093/jnci/86.20.1510 Silverman DT, Dunn JA, Hoover RN, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994;86:1510-6. 

    상세보기 crossref

  155. Int J Radiat Biol Phys WF Sindelar 12 148 1986 10.1016/0360-3016(86)90612-7 Sindelar WF, Kinsella TJ. Randomized trial of intraoperative radiotherapy in resected carcinoma of the pancreas. Int J Radiat Biol Phys 1986;12:148-52. 

    상세보기 crossref

  156. Cancer FP Smith 46 2014 1980 10.1002/1097-0142(19801101)46:9<2014::AID-CNCR2820460920>3.0.CO;2-D Smith FP, Hoth DF, Levin B, et al. 5-fluoruracil, adriamycin and mitomycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 1980;46:2014-8. 

    상세보기 crossref

  157. Proc Am Soc Clin Oncol FP Smith 3 150 1982 Smith FP, Stablein DM, Schein PS for the Gastrointestinal Tumor Study Group (GITSG). Phase II combination chemotherapy trials in advanced measurable pancreatic cancer. Proc Am Soc Clin Oncol 1982;3: 150-5. 

  158. 87 1997 UICC International Union Against Cancer. TNM classification of malignant tumours 5th edn. Sobin LK, Wittekind C, eds. UICC International Union Against Cancer. TNM classification of malignant tumours. 5th edn. New York: Wiley-Liss, 1997:87-90. 

  159. Lancet AG Speer 2 57 1987 10.1016/S0140-6736(87)92733-4 Speer AG, Cotton PB, Russel, RCG, et al. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;2:57-62. 

    상세보기 crossref

  160. Eur J Surg Oncol C Sperti 18 267 1992 Sperti C, Pasquali C, Catalini S, et al. Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin). Eur J Surg Oncol 1992;18:267-71. 

    상세보기

  161. Br J Surg OM Taylor 80 384 1993 10.1002/bjs.1800800341 Taylor OM, Benson EA, McMahon MJ, and the Yorkshire Gastrointestinal Tumour Group. Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. Br J Surg 1993;80:384-6. 

    상세보기 crossref

  162. Semin Oncol PRM Thomas 23 213 1996 Thomas PRM. Radiotherapy for carcinoma of the pancreas. Semin Oncol 1996;23:213-9. 

    상세보기

  163. Proc Am Soc Clin Oncol E Tian 111 184 1992 Tian E, Ardalan B, Benedetto P, et al. A phase II study of short term protracted infusion of high dose 5-fluoruracil (5-FU) with leucovorin (LV) and low-dose phophonoacetyl-L-aspartic acid (PALA) in pancreatic carcinoma. Proc Am Soc Clin Oncol 1992;111:184-8. 

  164. J Natl Cancer Inst MJ Tisdale 89 1763 1997 10.1093/jnci/89.23.1763 Tisdale MJ. Biology of cachexia (review). J Natl Cancer Inst 1997;89:1763-77. 

    상세보기 crossref

  165. Surg Gynaecol Obstet LW Traverso 146 959 1978 Traverso LW, Longmire WP. Preservation of the pylorus in pancreaticoduodenctomy. Surg Gynaecol Obstet 1978;146:959-62. 

  166. Ann Surg T Trede 211 447 1990 10.1097/00000658-199004000-00011 Trede T, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. Ann Surg 1990;211:447-58. 

    상세보기 crossref

  167. US Department of Health and Human Services, Public Health Services, Agency für Health Care Policy and Research. Management of cancer pain: Clinical practice guideline Number 9. AHCPR Publication No. 94-0592, 1994. 

  168. Am J Surg JA Heerden van 142 309 1981 10.1016/0002-9610(81)90336-6 van Heerden JA, ReMine WH, Weiland LH, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg 1981;142:309-11. 

    상세보기 crossref

  169. Cancer Chemother Pharmacol DJT Wagener 25 131 1989 10.1007/BF00692353 Wagener DJT, Hoesel QGCM, Van Yap SH. Phase II trial of 5-FU in locally advanced pancreatic cancer. Cancer Chemother Pharmacol 1989;25:131-4. 

    상세보기 crossref

  170. Cancer HJ Wanebo 78 Suppl 3 580 1996 10.1002/(SICI)1097-0142(19960801)78:3+<580::AID-CNCR2>3.0.CO;2-F Wanebo HJ, Vezeridis MP. Pancreatic carcinoma in perspective. A continuing challenge. Cancer 1996;78.Suppl 3: 580-91. 

    상세보기 crossref

  171. N Engl J Med AL Warshaw 326 455 1992 10.1056/NEJM199202133260706 Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65. 

    상세보기 crossref

  172. Br J Surg P Watanapa 79 8 1992 10.1002/bjs.1800790105 Watanapa P, Williamson RCN. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 1992;79:8-20. 

    상세보기 crossref

  173. N Engl J Med AJ Whelan 333 975 1995 10.1056/NEJM199510123331505 Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333:975-7. 

    상세보기 crossref

  174. J Clin Oncol R Whittington 13 227 1995 10.1200/JCO.1995.13.1.227 Whittington R, Neuberg D, Tester WJ, et al. Protracted intravenous fluoruracil infusion with radiation therapy in the management of localized pancreaticobiliary cancer: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 1995;13:227-32. 

    상세보기 crossref

  175. Br J Cancer SJ Wigmore 75 106 1997 10.1038/bjc.1997.17 Wigmore SJ, Plester CE, Richardson RA, et al. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 1997; 75:106-9. 

    상세보기 crossref

  176. Nutrition SJ Wigmore 12 27 1996 10.1016/0899-9007(95)00078-X Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996;12:27-30. 

    상세보기 crossref

  177. Eur J Cancer Clin Oncol J Wils 21 191 1985 10.1016/0277-5379(85)90172-5 Wils J, Bleiberg H, Blijham G, et al. Phase-II study of epirubicin in advanced adenocarcinoma of the pancreas. Eur J Cancer Clin Oncol 1985;21:191-4. 

    상세보기 crossref

  178. World Health Organization 1990 Cancer pain relief and palliative care 2nd edn. World Health Organization. Cancer pain relief and palliative care, 2nd edn. Geneva: World Health Organization, 1990. 

  179. Cancer Res Y Yamanaka 53 5289 1993 Yamanaka Y, Friess H, Büchler HW, et al. Overexpression of acidic and basis fibroblast growth factors in human pancreatic cancer correlates with advanced cancer stage. Cancer Res 1993;53:5289-96. 

    상세보기

  180. Anticancer Res Y Yamanaka 13 565 1993 Yamanaka Y, Friess H, Kobrin MS, et al. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer issociated with enhanced tumor aggressiveness. Anticancer Res 1993;13:565-70. 

    상세보기

  181. Proc Am Soc Clin Oncol M Yasue 11 161 1992 Yasue M, Sakamoto J, Kasui K, et al. A randomized trial of intraoperative radiation therapy (IORT) vs IORT plus chemotherapy (MTX-5-FU) for adenocarcinoma of the pancreas. Proc Am Soc Clin Oncol 1992;11: 161-8. 

  182. Ann Surg CJ Yeo 221 721 1995 10.1097/00000658-199506000-00011 Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. Ann Surg 1995;221:721-33. 

    상세보기 crossref

  183. Ann Surg CJ Yeo 225 621 1997 10.1097/00000658-199705000-00018 Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiaton improves survival. A prospective, single-institution experience. Ann Surg 1997;225:621-33. 

    상세보기 crossref

  184. Cancer A Zerbi 73 2930 1994 10.1002/1097-0142(19940615)73:12<2930::AID-CNCR2820731209>3.0.CO;2-M Zerbi A, Fossati V, Parolini D, et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 1994;73:2930-5. 

    상세보기 crossref

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로